Skip to main content

Find Clinical Trials

Home
Conditions
Plaque Psoriasis

Clinical trial condition

Plaque Psoriasis

Explore clinical trials studying Plaque Psoriasis. Study availability and eligibility vary by location and protocol.

295 public trials 26 recruiting studies

Refine in advanced search Browse all conditions

Plaque Psoriasis trial results

Completed

Study Evaluating Etanercept for the Treatment of Moderate to Severe Psoriasis

NCT00663052

Conditions: Plaque Psoriasis, Psoriasis, Skin Diseases, +2 more
Locations: Pfizer Investigational Site Capital Federal, Buenos Aires, Argentina

Pfizer Investigational Site Capital Federal, Buenos Aires, Argentina

Pfizer Investigational Site San Miguel, Buenos Aires, Argentina

Pfizer Investigational Site Feldkirch, Austria

View all 38 locations

View Trial Details

Completed

Study Evaluating Enbrel (Etanercept) in Adult Patients With Plaque Psoriasis

NCT00227240

Conditions: Plaque Psoriasis
Locations: Pfizer Investigational Site Munich, Germany

Pfizer Investigational Site München, Germany

View Trial Details

Completed

Amevive Wisdom Acquired From Real-Time Evidence (A.W.A.R.E™) Program

NCT00371774

Conditions: Plaque Psoriasis, Psoriasis, Skin Diseases, +2 more
Locations: Calgary, Alberta, Canada

Calgary, Alberta, Canada

Edmonton, Alberta, Canada

Edmonton, Alberta, Canada

View all 30 locations

View Trial Details

Completed

Safety and Efficacy of Adalimumab in Patients Who Showed an Unsatisfactory Response to Etanercept

NCT00927069

Conditions: Plaque Psoriasis
Locations: Winnipeg Clinic Winnipeg, Manitoba, Canada

NewLab Clinical Research St. John's, Newfoundland and Labrador, Canada

Mediprobe Research London, Ontario, Canada

The Guenther Dermatology Research center London, Ontario, Canada

View Trial Details

Completed

BTT1023 in Psoriasis

NCT00871598

Conditions: Plaque Psoriasis
Locations: Biotie investigational site Dresden, Germany

Biotie investigational site Leipzig, Germany

Biotie investigational site Berlin, State of Berlin, Germany

Biotie investigational site Berlin, State of Berlin, Germany

View Trial Details

Completed

Study to Investigate the Efficacy and the Safety of M518101 in Psoriasis Patients

NCT00884169

Conditions: Plaque Psoriasis
Locations: St Thomas' Hospital London, United Kingdom

View Trial Details

Completed

ACT-128800 in Psoriasis

NCT00852670

Conditions: Plaque Psoriasis
Locations: Landeskrankenhaus - Universitätsklilnikum Graz, Allgemeine Dermatologie Graz, Austria

University Klinik of Vienna Vienna, Austria

Departement de Pneumologie/ Unité Immunologie Clinique Allergie- Centre Hospitalier Lyon sud Lyon, France

CHU de Nice-Hôpital de l'Archet 2 / Service de dermatologie Nice, France

View all 14 locations

View Trial Details

Completed

A Single-Center Exploratory Study to Assess the Activity of CRx-197-002 in Plaque Psoriasis

NCT00796211

Conditions: Erythema, Pathological Conditions, Signs and Symptoms, Plaque Psoriasis, +7 more
Locations: ProInnovera Münster, Germany

View Trial Details

Completed

Study of CRx-191 to Assess Activity in Plaque Psoriasis

NCT00557739

Conditions: Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Plaque Psoriasis, +5 more
Locations: bioskin GmbH Berlin, Germany

View Trial Details

Completed

A Phase II Study of MEDI-507, Administered by Injection to Adults With Psoriasis

NCT00540618

Conditions: Plaque Psoriasis
Locations: MDS Pharma Services (US) Inc. Phoenix, Arizona, United States

Bressinck-Parker-Dinehart-Sangster Dermatology, PA Little Rock, Arkansas, United States

Associates in Research, Inc. Fresno, California, United States

nTouch Research Corporation San Diego, California, United States

View all 43 locations

View Trial Details